1
|
Machet A, Poudou C, Tomowiak C, Gastinne T, Gardembas M, Systchenko T, Moya N, Debiais C, Levy A, Gruchet C, Sabirou F, Noel S, Bouyer S, Leleu X, Delwail V, Guidez S. Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine. Blood Adv 2023; 7:3978-3983. [PMID: 36129842 PMCID: PMC10410126 DOI: 10.1182/bloodadvances.2021005557] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2021] [Revised: 10/21/2021] [Accepted: 11/14/2021] [Indexed: 11/20/2022] Open
Abstract
Preservation of fertility has become a growing concern in young females with Hodgkin lymphoma (HL). However, the rate of pregnancy after the current most frequently prescribed ABVD (doxorubicin [Adriamycin], bleomycin, vinblastine, and darcarbazine) chemotherapy for HL has rarely been studied. In this study, we aim to determine the impact of ABVD on the fertility of women treated for HL. We conducted a noninterventional, multicenter study of female patients of childbearing age who were treated for HL. Two healthy apparied women nonexposed to chemotherapy (our controls) were assigned for each patient. Fertility was assessed by the number of pregnancies and births after HL treatment. Sixty-seven patients were included. The median age at diagnosis was 24.4 years (range, 16-43). HL was a localized disease for 68.7%. Of all the patients, 53.7% started at least 1 pregnancy after treatment vs 54.5% of the controls (P = .92). Of all the patients who desired children, 81% had at least 1 pregnancy. Patients treated with ABVD did not have a longer median time to pregnancy (4.8 years in the group of patients and 6.8 years for controls). Across patients, there were 58 pregnancies and 48 births (ratio, 1:2) and 136 pregnancies and 104 births (ratio, 1:3) for the control cohort. No increase in obstetric or neonatal complications has been reported in HL in our study. The number of pregnancies, births, and the time to start a pregnancy in young women treated with ABVD for HL is not different from that of controls. Therefore, females with HL treated with ABVD should be reassured regarding fertility.
Collapse
Affiliation(s)
- Antoine Machet
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| | - Caroline Poudou
- Department of Medically Assisted Procreation, University Hospital of Poitiers, Poitiers, France
| | - Cécile Tomowiak
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| | - Thomas Gastinne
- Department of Hematology, University Hospital of Nantes, Nantes, France
| | - Martine Gardembas
- Department of Hematology, University Hospital of Angers, Angers, France
| | - Thomas Systchenko
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| | - Niels Moya
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| | - Celine Debiais
- Department of Anatomopathology, University Hospital of Poitiers, Poitiers, France
| | - Anthony Levy
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| | - Cécile Gruchet
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| | - Florence Sabirou
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| | - Stéphanie Noel
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| | - Sabrina Bouyer
- Department of Cytology, University Hospital of Poitiers, Poitiers, France
| | - Xavier Leleu
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| | - Vincent Delwail
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| | - Stéphanie Guidez
- Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France
| |
Collapse
|
2
|
Zhu F, Liu C, Qi J, Bian Y, Pang L, Lu Q. Psychometric properties of the Fertility Intention Scale among breast cancer patients of childbearing age in mainland China. Asia Pac J Oncol Nurs 2022; 9:100100. [PMID: 35860605 PMCID: PMC9289818 DOI: 10.1016/j.apjon.2022.100100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2022] [Accepted: 05/27/2022] [Indexed: 11/26/2022] Open
Abstract
Objective There are no valid assessment instruments assessing fertility intention among breast cancer survivors in mainland China. Therefore, this study aims to examine the psychometric properties of the Taiwanese version of the Fertility Intention Scale (FIS) among female patients with breast cancer of childbearing age in mainland China. Methods Two hundred and sixty-four female patients with breast cancer of childbearing age were recruited from two tertiary hospitals in Tianjin and Baoding, of which 32 patients completed the survey twice. Confirmatory factor analysis was adopted to assess construct validity. Correlations between the Reproductive Concerns After Cancer scale and FIS scores were calculated using Spearman correlation for convergent validity. The known-group validity of the FIS was verified using Mann–Whitney U test to compare the FIS scores between patients with or without the intention to conceive. Moreover, reliabilities were examined using Cronbach's alpha and intra-class correlation coefficient. Results Confirmatory factor analysis showed a good model fit to previous factor structures (χ2/df = 3.19, root mean square error of approximation = 0.091, comparative fitting index = 0.980, Tucker–Lewis index = 0.975), and no FIS item was dropped. The FIS scores were weak negatively correlated with the Reproductive Concerns After Cancer scale scores (r = –0.172, P < 0.01). The convergent validity of FIS was not satisfactory. Differences were noted between patients with or without the intention to conceive (50.62 ± 6.35 vs. 45.98 ± 7.19, P < 0.01). The FIS showed acceptable known-group validity. The internal consistency (Cronbach’s α = 0.824) and the test-retest reliability (r = 0.863, P < 0.01) of the FIS were also acceptable. Conclusions Overall, the FIS provides a comprehensive evaluation of the fertility intention among patients with breast cancer of childbearing age in mainland China. However, the convergent validity was not satisfactory; thus, further revision and validation may be required in the future.
Collapse
|
3
|
Lam CM, Shliakhtsitsava K, Stark SS, Medica ACO, Pinson KA, Whitcomb BW, Su HI. Reproductive intentions in childless female adolescent and young adult cancer survivors. Fertil Steril 2020; 113:392-399. [PMID: 32106992 DOI: 10.1016/j.fertnstert.2019.09.030] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2019] [Revised: 09/18/2019] [Accepted: 09/20/2019] [Indexed: 11/15/2022]
Abstract
OBJECTIVE To examine the association between prior cancer treatments, medical comorbidities, and voluntary childlessness in reproductive-age women who are survivors of cancers diagnosed as adolescents and young adults (AYA survivors). DESIGN Cross-sectional analysis. SETTING Participants were recruited from California and Texas cancer registries, fertility preservation programs, and cancer advocacy groups. PATIENT(S) Women (n = 413) ages 18-40 who were diagnosed with cancer between ages 15 and 35, completed primary cancer treatments, had at least one ovary, and were nulliparous. INTERVENTION(S) Cancer treatment gonadotoxicity and medical comorbidities. MAIN OUTCOME MEASURE(S) Voluntary childlessness. RESULT(S) The mean age of survivors was 31.8 years (SD, 4.9) with a mean of 6.5 years (SD, 4.4) since cancer diagnosis. Breast (26%), thyroid (19%), and Hodgkin lymphoma (18%) were the most common cancers. Twenty-two percent of the cohort was voluntarily childless. Medical comorbidities, cancer diagnosis, prior surgery, prior chemotherapy, and prior gonadotoxic treatments were not significantly associated with voluntary childlessness. In adjusted analysis, survivors of older reproductive age (adjusted odds ratio = 2.97 [1.71-5.18]) and nonheterosexual participants (adjusted odds ratio = 4.71 [2.15-10.32]) were more likely to report voluntary childlessness. CONCLUSION(S) A moderate proportion of AYA cancer survivors are voluntarily childless, but reproductive intentions were not related to cancer type or cancer treatments. AYA survivors of older age and nonheterosexual identification were more likely to be voluntarily childless. These data support assessing reproductive intentions and tailoring reproductive care such as fertility and contraception counseling that is appropriate for a survivor's intentions.
Collapse
Affiliation(s)
- Christina M Lam
- Department of Obstetrics, Gynecology and Reproductive Science, University of California, San Diego, La Jolla, California
| | - Ksenya Shliakhtsitsava
- Department of Pediatric Hematology/Oncology, University of Texas Southwestern, Dallas, Texas
| | - Shaylyn S Stark
- Moores Cancer Center, University of California, San Diego, La Jolla, California
| | - Alexa C O Medica
- Department of Obstetrics, Gynecology and Reproductive Science, University of California, San Diego, La Jolla, California
| | - Kelsey A Pinson
- Department of Obstetrics, Gynecology and Reproductive Science, University of California, San Diego, La Jolla, California
| | - Brian W Whitcomb
- Department of Biostatistics and Epidemiology, School of Public Health & Health Sciences, University of Massachusetts, Amherst, Massachusetts
| | - H Irene Su
- Department of Obstetrics, Gynecology and Reproductive Science, University of California, San Diego, La Jolla, California; Moores Cancer Center, University of California, San Diego, La Jolla, California.
| |
Collapse
|
4
|
Huang SM, Tseng LM, Lai JCY, Lien PJ, Chen PH. Oncofertility to Evidence-Based Practice: Changes in Fertility Intention and Symptom Burden in Reproductive-Age Women With Breast Cancer. Worldviews Evid Based Nurs 2019; 16:381-388. [PMID: 31149771 DOI: 10.1111/wvn.12374] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
BACKGROUND Infertility is negatively related to the quality of life in reproductive-age women with breast cancer. The nurses who care for these patients lack a comprehensive understanding of the changes in fertility intention that patients undergo from the time of cancer diagnosis, throughout treatment, and after treatment. A fertility intention assessment is the first step in discerning the patient's ideas toward future pregnancy. AIMS This study examined the changes in fertility intention and symptom burden in reproductive-age women with breast cancer before, during, and after treatment. We also explored predictors of fertility intention among the women. METHODS The study was guided by the theory of planned behavior. A longitudinal and observational study was conducted with 151 women with breast cancer who were treated at a teaching hospital in Taipei. The participants were interviewed using a structured questionnaire before, during, and after chemotherapy from July 2016 to March 2018. Fertility intention was assessed using the Fertility Intention Scale. The M.D. Anderson Symptom Inventory-Taiwanese version was used to measure the symptom burden. The generalized linear mixed model was used for multivariate analysis. RESULTS Patients had significantly lower scores for fertility intention after treatment than before treatment. The study patients had substantially worse symptom burden during treatment than before or after treatment. Symptom burden scores, especially for symptom interference, correlated significantly with fertility intention. A higher Fertility Intention Scale score was significantly associated with younger age. LINKING EVIDENCE TO ACTION Fertility intention decreased over time in women with breast cancer. Understanding fertility intention and controlling symptom burden throughout the course of treatment and beyond might help nurses provide better care for preserving fertility and maintaining fertility options for these women with breast cancer.
Collapse
Affiliation(s)
- Sheng-Miauh Huang
- Department of Nursing, Mackay Medical College, New Taipei City, Taiwan
| | - Ling-Ming Tseng
- Department of Surgery, Taipei Veterans General Hospital, and Professor, National Yang-Ming University, Taipei, Taiwan
| | - Jerry Cheng-Yen Lai
- Department of Medical Research, Taitung Mackay Memorial Hospital, Taitung, Taiwan
| | - Pei-Ju Lien
- Comprehensive Breast Health Center, Taipei Veterans General Hospital, Taipei, Taiwan
| | - Ping-Ho Chen
- Department of Traditional Chinese Medicine, Taipei Medical University Hospital, Taipei, Taiwan
| |
Collapse
|
5
|
van Dijk M, van den Berg MH, Overbeek A, Lambalk CB, van den Heuvel-Eibrink MM, Tissing WJ, Kremer LC, van der Pal HJ, Loonen JJ, Versluys B, Bresters D, Kaspers GJL, van Leeuwen FE, van Dulmen-den Broeder E. Reproductive intentions and use of reproductive health care among female survivors of childhood cancer. Hum Reprod 2019; 33:1167-1174. [PMID: 29617794 DOI: 10.1093/humrep/dey058] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2017] [Accepted: 03/07/2018] [Indexed: 11/13/2022] Open
Abstract
STUDY QUESTION Do female childhood cancer survivors (CCSs) express a decreased desire to have children and do they use reproductive health care more often compared to women without a history of cancer? SUMMARY ANSWER Overall, no difference was found in the desire to have children between CCSs and controls, whereas CCSs consult a fertility specialist more often, at a younger age, and sooner after their first attempt at conceiving. WHAT IS KNOWN ALREADY Female CCSs may face a shorter than anticipated reproductive window as a result of their cancer treatment. Little is known about their desire to have children and use of reproductive health care, especially in relation to their former cancer treatment. STUDY DESIGN, SIZE, DURATION This study is part of the DCOG LATER-VEVO study, a nationwide retrospective cohort study on female fertility in Dutch CCSs. In total, 1749 CCSs and 1673 controls were invited for the study. Data collection took place between January 2008 and May 2014. PARTICIPANTS/MATERIALS, SETTING, METHODS Data on the desire to have children and use of reproductive health care were collected by questionnaire. The control group consisted of sisters from CCSs and females from the general population. In total, 1106 (63%) CCSs and 818 (49%) controls completed the questionnaire. MAIN RESULTS AND THE ROLE OF CHANCE Overall, no difference was found in the desire to have children between CCSs and controls (86% and 89%, respectively). However, survivors of a CNS tumour were less likely to desire children and CCSs without biological children at time of study were more likely to report that their desire to have children was unfulfilled because of medical reasons (9%), compared to controls (1%). In total, 12% of CCSs ever consulted a fertility specialist compared to 10% of controls (OR = 1.7, 95% CI: 1.3-2.4). Mean (SD) age at time of their first visit was 27.7 (4.4) years for CCSs and 29.9 (3.9) years for controls (P < 0.01). In total, 43% of CCSs consulted a fertility specialist within 12 months after they had started trying to achieve a pregnancy, compared to 27% of controls. Risk factors for consulting a fertility specialist included a previous diagnosis of renal tumour, leukaemia, lymphoma or a CNS tumour, and treatment with alkylating chemotherapy, gonadotoxic radiotherapy or both. In total, 70% of CCSs reported a female factor as cause of subfertility compared to 34% of controls (OR = 4.5, 95% CI: 2.3-8.7) and in this specific group, CCSs seemed more likely to use fertility treatment (OR = 2.9, 95% CI: 1.0-8.2). LIMITATIONS, REASONS FOR CAUTION Because of the low number of CCSs who used fertility treatment, we were not able to look at specific diagnoses and treatment types associated with using fertility treatment. Nevertheless, we were able to identify diagnostic- and treatment-related risk factors for consulting a fertility specialist. Details regarding consultations with a fertility specialist and fertility treatment were based on self-report and may therefore be subject to recall bias. WIDER IMPLICATIONS OF THE FINDINGS Decisions about parenthood affect all CCSs. It's important to evaluate reproductive intentions and function timely after cancer treatment, so CCSs can be adequately counselled regarding family planning and fertility treatment. STUDY FUNDING/COMPETING INTEREST(S) This work was supported by the Dutch Cancer Society (Grant no. VU 2006-3622) and the Children Cancer Free Foundation (Project no. 20). TRIAL REGISTRATION NUMBER NTR2922.
Collapse
Affiliation(s)
- M van Dijk
- Department of Paediatrics, Division of Oncology-Haematology, VU University Medical Center, PO Box 7057, 1000 MB Amsterdam, The Netherlands
| | - M H van den Berg
- Department of Paediatrics, Division of Oncology-Haematology, VU University Medical Center, PO Box 7057, 1000 MB Amsterdam, The Netherlands
| | - A Overbeek
- Department of Paediatrics, Division of Oncology-Haematology, VU University Medical Center, PO Box 7057, 1000 MB Amsterdam, The Netherlands.,Department of Obstetrics and Gynaecology, VU University Medical Center, PO Box 7057, 1000 MB Amsterdam, The Netherlands
| | - C B Lambalk
- Department of Obstetrics and Gynaecology, VU University Medical Center, PO Box 7057, 1000 MB Amsterdam, The Netherlands
| | - M M van den Heuvel-Eibrink
- Princess Máxima Center for Paediatric Oncology, Lundlaan 6, 3584 EA Utrecht, The Netherlands.,Department of Paediatric Oncology/Haematology, Sophia Childrens' Hospital/Erasmus MC-University Medical Center, Wytemaweg 40, 3015 GJ Rotterdam, The Netherlands
| | - W J Tissing
- Department of Paediatric Oncology/Haematology, University of Groningen, University Medical Center Groningen, PO Box 3001, 9700 RB Groningen, The Netherlands
| | - L C Kremer
- Department of Paediatric Oncology, Emma Children's Hospital/Amsterdam Medical Center, PO Box 22660, 1100 DD Amsterdam, The Netherlands
| | - H J van der Pal
- Princess Máxima Center for Paediatric Oncology, Lundlaan 6, 3584 EA Utrecht, The Netherlands
| | - J J Loonen
- Department of Haematology, Radboud University, Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands
| | - B Versluys
- Department of Paediatric Oncology, Wilhelmina Children's Hospital/University Medical Center Utrecht, PO Box 85090, 3508 AB Utrecht, The Netherlands
| | - D Bresters
- Willem-Alexander Children's Hospital/Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
| | - G J L Kaspers
- Department of Paediatrics, Division of Oncology-Haematology, VU University Medical Center, PO Box 7057, 1000 MB Amsterdam, The Netherlands.,Princess Máxima Center for Paediatric Oncology, Lundlaan 6, 3584 EA Utrecht, The Netherlands
| | - F E van Leeuwen
- Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
| | - E van Dulmen-den Broeder
- Department of Paediatrics, Division of Oncology-Haematology, VU University Medical Center, PO Box 7057, 1000 MB Amsterdam, The Netherlands
| | | |
Collapse
|
6
|
Fertility status perception, fertility preservation and desire to have children in cancer survivors: French VICAN survey. Future Sci OA 2018; 4:FSO343. [PMID: 30450230 PMCID: PMC6234464 DOI: 10.4155/fsoa-2018-0018] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2018] [Accepted: 07/27/2018] [Indexed: 01/23/2023] Open
Abstract
Aim To report fertility status perception, fertility preservation and desire to have children in French cancer survivors 2 and 5 years after diagnosis. Methods A total of 427 women and 115 men self-reported treatment-induced infertility, fertility status, access to gamete conservation, desire to have children and pregnancy/live births. Results A total of 96.5% of men and 92.9% of women were thought to be fertile at diagnosis and 38% desired to have children. A total of 57.8% of men and 67.4% of women declared that no fertility preservation had been discussed before treatment. After 2 years, 26.8% of patients still desired to have children. After 5 years, 18 live births have been reported. Conclusion Despite a legal obligation and technical progress, there is a lack of information given to patients.
Collapse
|
7
|
Birth rates among male cancer survivors and mortality rates among their offspring: a population-based study from Sweden. BMC Cancer 2016; 16:196. [PMID: 26955945 PMCID: PMC4782514 DOI: 10.1186/s12885-016-2236-y] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2014] [Accepted: 03/01/2016] [Indexed: 12/03/2022] Open
Abstract
Background With improvements in treatment of cancer, more men of fertile age are survivors of cancer. This study evaluates trends in birth rates among male cancer survivors and mortality rates of their offspring. Methods From the Swedish Multi-generation Register and Cancer Register, we identified 84,752 men ≤70 years with a history of cancer, for which we calculated relative birth rates as compared to the background population(Standardized Birth Ratios, SBRs). We also identified 126,696 offspring of men who had cancer, and compared their risks of death to the background population(Standardized Mortality Ratio, SMRs). Independent factors associated with reduced birth rates and mortality rates were estimated with Poisson modelling. Results Men with a history of cancer were 23 % less likely to father a child compared to the background population(SBR 0.77, 95 % Confidence Interval[CI] 0.75–0.79). Nulliparous men were significantly more likely to father a child after diagnosis (SBR 0.81, 95 % CI 0.79–0.83) compared to parous men (SBR 0.68, 95 % CI 0.66–0.74). Cancer site(prostate), onset of cancer during childhood or adolescence, parity status at diagnosis(parous), current age(>40 years) and a recent diagnosis were significant and independent predictors of a reduced probability of fathering a child after diagnosis. Of the 126,696 children born to men who have had a diagnosis of cancer, 2604(2.06 %) died during follow up. The overall mortality rate was similar to the background population(SMR of 1.00, 95 %CI 0.96–1.04) and was not affected by the timing of their birth in relation to father’s cancer diagnosis. Conclusion Male cancer survivors are less likely to father a child compared to the background population. This is influenced by cancer site, age of onset and parity status at diagnosis. However, their offspring are not at an increased risk of death.
Collapse
|
8
|
Bouhnik AD, Bendiane MK, Cortaredona S, Sagaon Teyssier L, Rey D, Berenger C, Seror V, Peretti-Watel P. The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open 2015; 5:e005971. [PMID: 25805526 PMCID: PMC4386221 DOI: 10.1136/bmjopen-2014-005971] [Citation(s) in RCA: 57] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
INTRODUCTION Today, a growing need exists for greater research into cancer survivorship, focusing on different spheres of the day-to-day life of diagnosed patients. This article describes the design and implementation of VICAN (VIe après le CANcer), a national survey on French cancer survivors. METHOD AND ANALYSIS The target population included patients aged 18-82, diagnosed with cancer between January and June 2010, and registered in one of the three main French Health Insurance Schemes. It was restricted to 12 tumour sites. Sampling was stratified using a non-proportional allocation, based on age at diagnosis (18-52 and 53-82) and tumour site. Data were collected from telephone interviews with patients 2 and 5 years after diagnosis, a medical survey completed by the physician who initiated cancer treatment, and information from the national medicoadministrative database on reimbursement data and hospital discharge records. First data collection, 2 years after diagnosis, occurred between March and December 2012. Second data collection, 5 years after diagnosis, will be conducted in 2015. Analyses will be conducted on various outcomes: quality of life, health status and psychosocial conditions, with a particular focus on the impact of cancer diagnosis on the labour market. The variety of measurements included in the survey will enable us to control a wide range of factors. ETHICS AND DISSEMINATION The methodology of the VICAN survey was approved by three national ethics commissions. Results of the study will be disseminated through national and international research conferences, and in articles published in international peer-reviewed journals.
Collapse
Affiliation(s)
- Anne-Deborah Bouhnik
- INSERM, UMR912 “Economics and Social Sciences Applied to Health & Analysis of Medical Information” (SESSTIM), Marseille, France
- Aix Marseille University, UMR_S912, IRD, Marseille, France
| | - Marc-Karim Bendiane
- INSERM, UMR912 “Economics and Social Sciences Applied to Health & Analysis of Medical Information” (SESSTIM), Marseille, France
- Aix Marseille University, UMR_S912, IRD, Marseille, France
- ORS PACA, Southeastern Health Regional Observatory, Marseille, France
| | - Sebastien Cortaredona
- INSERM, UMR912 “Economics and Social Sciences Applied to Health & Analysis of Medical Information” (SESSTIM), Marseille, France
- Aix Marseille University, UMR_S912, IRD, Marseille, France
- ORS PACA, Southeastern Health Regional Observatory, Marseille, France
| | - Luis Sagaon Teyssier
- INSERM, UMR912 “Economics and Social Sciences Applied to Health & Analysis of Medical Information” (SESSTIM), Marseille, France
- Aix Marseille University, UMR_S912, IRD, Marseille, France
- ORS PACA, Southeastern Health Regional Observatory, Marseille, France
| | - Dominique Rey
- INSERM, UMR912 “Economics and Social Sciences Applied to Health & Analysis of Medical Information” (SESSTIM), Marseille, France
- Aix Marseille University, UMR_S912, IRD, Marseille, France
- ORS PACA, Southeastern Health Regional Observatory, Marseille, France
| | - Cyril Berenger
- INSERM, UMR912 “Economics and Social Sciences Applied to Health & Analysis of Medical Information” (SESSTIM), Marseille, France
- Aix Marseille University, UMR_S912, IRD, Marseille, France
- ORS PACA, Southeastern Health Regional Observatory, Marseille, France
| | - Valerie Seror
- INSERM, UMR912 “Economics and Social Sciences Applied to Health & Analysis of Medical Information” (SESSTIM), Marseille, France
- Aix Marseille University, UMR_S912, IRD, Marseille, France
| | - Patrick Peretti-Watel
- INSERM, UMR912 “Economics and Social Sciences Applied to Health & Analysis of Medical Information” (SESSTIM), Marseille, France
- Aix Marseille University, UMR_S912, IRD, Marseille, France
- ORS PACA, Southeastern Health Regional Observatory, Marseille, France
| | | |
Collapse
|
9
|
Schmidt R, Richter D, Sender A, Geue K. Motivations for having children after cancer - a systematic review of the literature. Eur J Cancer Care (Engl) 2014; 25:6-17. [DOI: 10.1111/ecc.12276] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/04/2014] [Indexed: 11/30/2022]
Affiliation(s)
- R. Schmidt
- Department of Medical Psychology and Medical Sociology; University of Leipzig; Leipzig Germany
| | - D. Richter
- Department of Medical Psychology and Medical Sociology; University of Leipzig; Leipzig Germany
| | - A. Sender
- Department of Medical Psychology and Medical Sociology; University of Leipzig; Leipzig Germany
| | - K. Geue
- Department of Medical Psychology and Medical Sociology; University of Leipzig; Leipzig Germany
| |
Collapse
|
10
|
La plateforme régionale « Cancer et fertilité »: un projet pilote du réseau ONCOPACA-Corse. ONCOLOGIE 2013. [DOI: 10.1007/s10269-013-2279-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Préaubert L, Poggi P, Pibarot M, Delotte J, Thibault E, Saias-Magnan J, Courbière B. [Fertility preservation among patients with cancer: report of a French regional practical experience]. ACTA ACUST UNITED AC 2013; 42:246-51. [PMID: 23453919 DOI: 10.1016/j.jgyn.2013.01.003] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2012] [Revised: 01/02/2013] [Accepted: 01/23/2013] [Indexed: 01/27/2023]
Abstract
OBJECTIVE Improvement in cancer treatments has led to reconsider the importance of quality of life after cancer, especially concerning maintening the potential of fertility since it is often altered after healing. Our objective was to estimate the knowledge and practices of the physicians in the field of Oncology in a French Region (Provence Alpes- Côte d'Azur). PATIENTS AND METHOD Prospective survey, conducted between January and April 2012, amongst oncologists working in Provence Alpes Côte d'Azur region, through questionnaires distributed during multidisciplinary meetings in oncology. RESULTS Among 225 replies, 54% of the physicians had sent no patient to any oncofertility consultation during the previous six months (n=120). Besides, 33% of the oncologists (n=68) declared they had difficulties in addressing their patients to oncofertility consultation, and 58% of them (n=39) considered they lacked information on techniques and indications of fertility preservation. CONCLUSION This study provides an estimation of the current practices in PACA region concerning oncofertility and underlines the physicians' need of information. In this context, the regional oncology network has set up a regional network « cancer and fertility » in order to facilitate the access to fertility preservation prior to any potentially sterilizing treatment for all patients.
Collapse
Affiliation(s)
- L Préaubert
- Pôle de gynécologie-obstétrique et reproduction (Pr-Gamerre), hôpital de La Conception, AP-HM, 147, boulevard Baille, 13385 Marseille, France.
| | | | | | | | | | | | | |
Collapse
|
12
|
Jacobs LA, Pucci DA. Adult Survivors of Childhood Cancer: The Medical and Psychosocial Late Effects of Cancer Treatment and the Impact on Sexual and Reproductive Health. J Sex Med 2013; 10 Suppl 1:120-6. [DOI: 10.1111/jsm.12050] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
|
13
|
Préau M, Bouhnik AD, Le Coroller Soriano AG. Two years after cancer diagnosis, what is the relationship between health-related quality of life, coping strategies and spirituality? PSYCHOL HEALTH MED 2012; 18:375-86. [PMID: 23140373 DOI: 10.1080/13548506.2012.736622] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
This study aimed to analyze the relationship between spirituality, coping strategies and health-related quality of life (HRQL) among a large representative sample of patients two years after cancer diagnosis. Using a cross-sectional design, medical and self-reported data were collected by physicians and a patient telephone interview, respectively. Among 4270 participants, 54.6% reported that spirituality was not a source of comfort at all during the disease, 23.4% stated that it was a source of moderate comfort and 22.5% a source of great comfort. After adjustment for age, gender, educational level and living in a couple, a multivariate analysis showed that a lower mental HRQL score was independently associated with finding moderate comfort in spirituality when compared with finding no comfort at all. After multiple adjustment, a lower score of physical HRQL and a higher score of fighting spirit were independently associated with having found great comfort in spirituality when compared with those who found no comfort at all. This study aimed to understand the dynamics of religious beliefs among cancer patients over the disease duration and to understand how these beliefs could be considered and utilized by patients as a source of comfort and support. The results highlight not only the role spirituality may play in disease management and the extent to which it may be a valuable source of comfort during the follow-up of cancer patients, but also its role in the evaluation of the different dimensions of HRQL.
Collapse
Affiliation(s)
- Marie Préau
- GREPS, Psychology Institute, Lyon 2 University, Bron, France.
| | | | | | | |
Collapse
|
14
|
Falorio S, Biasoli I, Luminari S, Quintana G, Musso M, Dell'Olio M, Specchia MR, di Renzo N, Cesaretti M, Buda G, Vallisa D, Mannina D, Andriani A, Chiattone CS, Delamain MT, de Souza CA, Spector N, Angrilli F, Federico M. Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions. Hematol Oncol 2012; 31:72-8. [DOI: 10.1002/hon.2029] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2012] [Revised: 08/19/2012] [Accepted: 09/05/2012] [Indexed: 11/11/2022]
Affiliation(s)
- Simona Falorio
- Dipartimento di Ematologia; Ospedale Civile Spirito Santo; Pescara; Italy
| | - Irene Biasoli
- Department of Medicine, University Hospital and School of Medicine; Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil
| | - Stefano Luminari
- Dipartimento di Oncologia ed Ematologia; Università degli studi di Modena; Modena; Italy
| | | | - Maurizio Musso
- Dipartimento di Ematologia; Ospedale La Maddalena; Palermo; Italy
| | - Matteo Dell'Olio
- Dipartimento di Ematologia; Ospedale Casa Sollievo della Sofferenza; San Giovanni Rotondo; Italy
| | | | | | - Marina Cesaretti
- Dipartimento di Oncologia ed Ematologia; Università degli studi di Modena; Modena; Italy
| | - Gabriele Buda
- Dipartimento di Ematologia; Università di Pisa; Pisa; Italy
| | | | - Donato Mannina
- Divisione di Ematologia; Ospedale Papardo; Messina; Italy
| | | | | | - Márcia Torresan Delamain
- Center of Hematology and Hemotherapy, Department of Internal Medicine, Faculty of Medicine; State University of Campinas; Campinas-SP; Brazil
| | - Cármino A de Souza
- Center of Hematology and Hemotherapy, Department of Internal Medicine, Faculty of Medicine; State University of Campinas; Campinas-SP; Brazil
| | - Nelson Spector
- Department of Medicine, University Hospital and School of Medicine; Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil
| | - Francesco Angrilli
- Dipartimento di Ematologia; Ospedale Civile Spirito Santo; Pescara; Italy
| | - Massimo Federico
- Dipartimento di Oncologia ed Ematologia; Università degli studi di Modena; Modena; Italy
| |
Collapse
|
15
|
Current world literature. Curr Opin Urol 2011; 21:535-40. [PMID: 21975510 DOI: 10.1097/mou.0b013e32834c87d0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|